Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
Global medical technology company, Baxter International, has announced a quarterly cash dividend of $0.29 per share. This demonstrates their commitment ...
Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...